Comparison of Vicious Effect of Oral Pantoprazole and Famotidine on New Bone Formation in Patients With Lumbar Spine Fusion Surgery: A Randomized Control Trial

Background and Aim: Due to the increasing use of proton pump inhibitors (PPIs) and their side effects for bone repair and the high percentage of therapy failure in lumbar fusion surgery, especially in various animal studies, the goal of this study was to appraise the consequence of pantoprazole and...

Full description

Saved in:
Bibliographic Details
Main Authors: Kaveh Haddadi, Navid Tahmasbi, Abdolrasool Alaee, Abbas Alipour, Saeed Ehteshami
Format: Article
Language:English
Published: Guilan University of Medical Sciences 2024-01-01
Series:Iranian Journal of Neurosurgery
Subjects:
Online Access:http://irjns.org/article-1-366-en.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850209848760729600
author Kaveh Haddadi
Navid Tahmasbi
Abdolrasool Alaee
Abbas Alipour
Saeed Ehteshami
author_facet Kaveh Haddadi
Navid Tahmasbi
Abdolrasool Alaee
Abbas Alipour
Saeed Ehteshami
author_sort Kaveh Haddadi
collection DOAJ
description Background and Aim: Due to the increasing use of proton pump inhibitors (PPIs) and their side effects for bone repair and the high percentage of therapy failure in lumbar fusion surgery, especially in various animal studies, the goal of this study was to appraise the consequence of pantoprazole and famotidine on new bone formation in patients experiencing spinal fusion surgery. Methods and Materials/Patients: In this double-blind clinical trial, eighty patients participated based on the inclusion and exclusion criteria, of whom 40 cases received pantoprazole (group P) and 40 received famotidine (group F) for eight weeks. They were followed up for three, six, and twelve months after surgery for cage subsidence, screw loosening, and visual analogue scale (VAS), Oswestry disability index (ODI), Brantigan, Steffee, Fraser (BSF), and Lenke classification for grading their bone formation. A P<0.05 was considered significant. Results: The rate of fusion based on the Lenke score was lower in the group receiving pantoprazole six and 12 months after the surgery compared to group F (the frequency of Lenke grades C and D were 35% and 25% compared to the famotidine group 12.5% and 12.5%, respectively; P=0.042). The VAS Mean±SD score in group F was lower than group P after 12 months (2.48±1.06 and 1.83±0.55, respectively; P=0.008). There was no pharmacologically significant association between subsidence (P=0.43), loosening (P=0.13), ODI (P=0.31), and BSF (P=0.77) 3, 6 and 12 months post-operation. Conclusion: Affording to the preliminary conclusions of this study, the use of pump inhibitors, such as pantoprazole is more destructive for the ossification process in candidates for spinal fusion requiring the chronic use of drugs for controlling their gastric acid secretion, and H2-blocking drugs, such as famotidine are preferable in this situation after further investigations.
format Article
id doaj-art-ea2bb22d33b04476b2ec755d2f340040
institution OA Journals
issn 2423-6497
2423-6829
language English
publishDate 2024-01-01
publisher Guilan University of Medical Sciences
record_format Article
series Iranian Journal of Neurosurgery
spelling doaj-art-ea2bb22d33b04476b2ec755d2f3400402025-08-20T02:09:55ZengGuilan University of Medical SciencesIranian Journal of Neurosurgery2423-64972423-68292024-01-0110Continuous Publishing00Comparison of Vicious Effect of Oral Pantoprazole and Famotidine on New Bone Formation in Patients With Lumbar Spine Fusion Surgery: A Randomized Control TrialKaveh Haddadi0Navid Tahmasbi1Abdolrasool Alaee2Abbas Alipour3Saeed Ehteshami4 Department of Neurosurgery, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran. Department of Neurosurgery, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran. Orthopedics Research Center, Mazandaran University of Medical Sciences, Sari, Iran. Orthopedics Research Center, Mazandaran University of Medical Sciences, Sari, Iran. Orthopedics Research Center, Mazandaran University of Medical Sciences, Sari, Iran. Background and Aim: Due to the increasing use of proton pump inhibitors (PPIs) and their side effects for bone repair and the high percentage of therapy failure in lumbar fusion surgery, especially in various animal studies, the goal of this study was to appraise the consequence of pantoprazole and famotidine on new bone formation in patients experiencing spinal fusion surgery. Methods and Materials/Patients: In this double-blind clinical trial, eighty patients participated based on the inclusion and exclusion criteria, of whom 40 cases received pantoprazole (group P) and 40 received famotidine (group F) for eight weeks. They were followed up for three, six, and twelve months after surgery for cage subsidence, screw loosening, and visual analogue scale (VAS), Oswestry disability index (ODI), Brantigan, Steffee, Fraser (BSF), and Lenke classification for grading their bone formation. A P<0.05 was considered significant. Results: The rate of fusion based on the Lenke score was lower in the group receiving pantoprazole six and 12 months after the surgery compared to group F (the frequency of Lenke grades C and D were 35% and 25% compared to the famotidine group 12.5% and 12.5%, respectively; P=0.042). The VAS Mean±SD score in group F was lower than group P after 12 months (2.48±1.06 and 1.83±0.55, respectively; P=0.008). There was no pharmacologically significant association between subsidence (P=0.43), loosening (P=0.13), ODI (P=0.31), and BSF (P=0.77) 3, 6 and 12 months post-operation. Conclusion: Affording to the preliminary conclusions of this study, the use of pump inhibitors, such as pantoprazole is more destructive for the ossification process in candidates for spinal fusion requiring the chronic use of drugs for controlling their gastric acid secretion, and H2-blocking drugs, such as famotidine are preferable in this situation after further investigations.http://irjns.org/article-1-366-en.pdfpantoprazole sodiumfamotidine hydrochloridespinal fusions
spellingShingle Kaveh Haddadi
Navid Tahmasbi
Abdolrasool Alaee
Abbas Alipour
Saeed Ehteshami
Comparison of Vicious Effect of Oral Pantoprazole and Famotidine on New Bone Formation in Patients With Lumbar Spine Fusion Surgery: A Randomized Control Trial
Iranian Journal of Neurosurgery
pantoprazole sodium
famotidine hydrochloride
spinal fusions
title Comparison of Vicious Effect of Oral Pantoprazole and Famotidine on New Bone Formation in Patients With Lumbar Spine Fusion Surgery: A Randomized Control Trial
title_full Comparison of Vicious Effect of Oral Pantoprazole and Famotidine on New Bone Formation in Patients With Lumbar Spine Fusion Surgery: A Randomized Control Trial
title_fullStr Comparison of Vicious Effect of Oral Pantoprazole and Famotidine on New Bone Formation in Patients With Lumbar Spine Fusion Surgery: A Randomized Control Trial
title_full_unstemmed Comparison of Vicious Effect of Oral Pantoprazole and Famotidine on New Bone Formation in Patients With Lumbar Spine Fusion Surgery: A Randomized Control Trial
title_short Comparison of Vicious Effect of Oral Pantoprazole and Famotidine on New Bone Formation in Patients With Lumbar Spine Fusion Surgery: A Randomized Control Trial
title_sort comparison of vicious effect of oral pantoprazole and famotidine on new bone formation in patients with lumbar spine fusion surgery a randomized control trial
topic pantoprazole sodium
famotidine hydrochloride
spinal fusions
url http://irjns.org/article-1-366-en.pdf
work_keys_str_mv AT kavehhaddadi comparisonofviciouseffectoforalpantoprazoleandfamotidineonnewboneformationinpatientswithlumbarspinefusionsurgeryarandomizedcontroltrial
AT navidtahmasbi comparisonofviciouseffectoforalpantoprazoleandfamotidineonnewboneformationinpatientswithlumbarspinefusionsurgeryarandomizedcontroltrial
AT abdolrasoolalaee comparisonofviciouseffectoforalpantoprazoleandfamotidineonnewboneformationinpatientswithlumbarspinefusionsurgeryarandomizedcontroltrial
AT abbasalipour comparisonofviciouseffectoforalpantoprazoleandfamotidineonnewboneformationinpatientswithlumbarspinefusionsurgeryarandomizedcontroltrial
AT saeedehteshami comparisonofviciouseffectoforalpantoprazoleandfamotidineonnewboneformationinpatientswithlumbarspinefusionsurgeryarandomizedcontroltrial